ExSight Ventures
Thesis
Drawing on our unique domain expertise and utilizing capital efficient techniques, ExSight invests in early-stage companies that are developing breakthrough technologies to aid, diagnose, and treat large populations of those afflicted with vision diseases.
Stages
Pre-SeedSeedSeries ASeries B
Sectors
BiotechHealthcare/MedtechLife SciencesAI/ML